Log In
BCIQ
Print this Print this
 

GliAtak

  Manage Alerts
Collapse Summary General Information
Company Advantagene Inc.
DescriptionAdV-tk and valacyclovir gene therapy
Molecular Target
Mechanism of ActionGene therapy; Vaccine
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat malignant glioma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today